A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Methods: Lung tissue for the generation of primary swine respiratory ... In this study, we developed an immortalized swine bronchial epithelial cell line for IAV research by introducing Simian Virus ...